BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1094 related articles for article (PubMed ID: 26675759)

  • 1. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity.
    Karimi K; Karimi Y; Chan J; Boudreau JE; Basset J; Chew MV; Reid S; Bramson JL; Wan Y; Ashkar AA
    Innate Immun; 2015 Aug; 21(6):626-34. PubMed ID: 25749844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
    J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells.
    Bosch NC; Martin LM; Voskens CJ; Berking C; Seliger B; Schuler G; Schaft N; Dörrie J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.
    Van den Bergh JMJ; Smits ELJM; Versteven M; De Reu H; Berneman ZN; Van Tendeloo VFI; Lion E
    J Immunol Res; 2017; 2017():1975902. PubMed ID: 28785596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
    Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
    Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.
    Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
    Leuk Res; 2009 Apr; 33(4):539-46. PubMed ID: 18845337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
    Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.
    Hansen ML; Woetmann A; Krejsgaard T; Kopp KL; Søkilde R; Litman T; Straten PT; Geisler C; Wasik MA; Odum N; Eriksen KW
    Mol Immunol; 2011 Sep; 48(15-16):2087-93. PubMed ID: 21813181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
    Morandi B; Mortara L; Carrega P; Cantoni C; Costa G; Accolla RS; Mingari MC; Ferrini S; Moretta L; Ferlazzo G
    Int Immunol; 2009 May; 21(5):599-606. PubMed ID: 19325034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
    Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
    Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.
    Terme M; Tomasello E; Maruyama K; Crépineau F; Chaput N; Flament C; Marolleau JP; Angevin E; Wagner EF; Salomon B; Lemonnier FA; Wakasugi H; Colonna M; Vivier E; Zitvogel L
    J Immunol; 2004 May; 172(10):5957-66. PubMed ID: 15128777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help.
    Steel JC; Ramlogan CA; Yu P; Sakai Y; Forni G; Waldmann TA; Morris JC
    Cancer Res; 2010 Feb; 70(3):1072-81. PubMed ID: 20086176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity.
    Miller G; Lahrs S; Dematteo RP
    FASEB J; 2003 Apr; 17(6):728-30. PubMed ID: 12594171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells.
    Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H
    Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
    Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
    Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.